JPRN-UMIN000037722
Recruiting
未知
Safety and antihypertensive effect of switching from eplerenone to esaxerenone in hypertensive patients. - Safety and antihypertensive effect of switching from eplerenone to esaxerenone in hypertensive patients.
Tokyo Women's Medical University0 sites200 target enrollmentAugust 19, 2019
Conditionshypertensive patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hypertensive patients
- Sponsor
- Tokyo Women's Medical University
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with heart failure. Patients who have taken potassium\-sparing diuretics (spironolactone, triamterene, and potassium canrenoate) or potassium preparations during the last 8 weeks. Patients whose serum potassium level exceeded 5\.0 mEq/L. Patients with severe renal dysfunction (eGFR \<30 mL/min/1\.73m2\).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
In hypertensive patients; effect of induction of anesthesia on cerebral tissue oxygen saturatiohypertensionAnaesthesiology - AnaestheticsCardiovascular - HypertensionACTRN12618000506291YASIN TASKALDIRA200
Recruiting
Phase 4
Comparison of blood pressure lowering effect of drugs.Health Condition 1: null- HypertensionCTRI/2017/09/009725Indira Gandhi Medical College134
Completed
Not Applicable
Comparison of hypotensive effect and prevention to progression of diabetic nephrolopathy with Olmesartan and Ca channel blocker in patient of type 2 diabetichypertension with type 2 diabetisJPRN-UMIN000004253Endcrinology and Diabetis,Saitama Medical University150
Completed
Phase 4
Antihypertensive effect of combination therapy of telmisartan and low dose hydrochrolthiazide in hypertemnsive patientsJPRN-UMIN000000798on profit Organization LINE60
Completed
Not Applicable
EVALUATION OF ANTIHYPERTENSIVE EFFECTS OF FREQUENT thermoneutral BATHS, A RANDOMIZED CONTROLLED TRIAI10.0DRKS00003980niversitätsklinikum Freiburg59